Scinopharm Taiwan Ltd. | Date: 2015-10-28
Crystalline forms of pemetrexed diacid are provided (Forms 1 and 2) which are readily produced for either laboratory-scale or industrial scale. Processes for the preparation of Forms 1 and 2 are also provided.
ScinoPharm Taiwan Ltd. | Date: 2015-04-10
The present application discloses a stereoselective process for the preparation of -C-arylglucosides that does not require the use of conventional carbohydrate protecting groups.
Scinopharm Taiwan Ltd. | Date: 2013-09-18
A compound of formula (X): which can be used as an intermediate to make lapatinib or its pharmaceutically acceptable salt.
ScinoPharm Taiwan Ltd. | Date: 2013-12-18
The invention provides a process for the preparation of leuprolide or its pharmaceutical acceptable salts by a combination of solid phase synthesis and post assembly solution phase amidation. The invention also relates to applying a non-protected leuprolide precursor to prepare leuprolide or its pharmaceutically acceptable salts.
ScinoPharm Taiwan Ltd. | Date: 2013-08-12
The present invention provides crystalline forms, including an anhydrate form, of cabazitaxel and processes for the preparation of these forms, designated as Forms C1, C2, C3, C4, C5, C6, C7, C8, C8b, C9 and C9p.